Ledger.Open graph →
SEC Form D · Amendment · filed May 2, 2025

Mivax Therapeutics, Inc

Offering
$150K
Sold
$108K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Pragyesh B. Dhungel · San Francisco, CAExecViraj B. Deshpande · San Francisco, CAExecPragyesh B. Dhungel · San Francisco, CAExecViraj B. Deshpande · San Francisco, CAExecHelen Koo · San Francisco, CAExecMatthew Colpoys · Buffalo, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗